Cargando…
Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
Autores principales: | Bai, Wei, Li, Mengtao, Zhou, Shuang, Peng, Liying, Zhao, Jiuliang, Tian, Xinping, Wang, Qian, Leng, Xiaomei, Zhang, Shangzhu, Wang, Yanhong, Zhao, Yan, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771338/ https://www.ncbi.nlm.nih.gov/pubmed/35946790 http://dx.doi.org/10.1097/CM9.0000000000002302 |
Ejemplares similares
-
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022) -
Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
por: Wang, Minhui, et al.
Publicado: (2022) -
Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
por: Peng, Liying, et al.
Publicado: (2020) -
Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
por: Wang, Ziqian, et al.
Publicado: (2015) -
Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)